▁The 10.375
▁article 8.796875
▁" 3.875
Chr 8.65625
onic 2.2109375
▁In 4.48828125
fl 0.090576171875
amm 1.34375
ation 0.6767578125
▁in 3.837890625
▁End 6.8984375
- 3.41015625
Stage 1.865234375
▁Ren 2.78515625
al 3.173828125
▁D 4.046875
ise 0.42138671875
ase 0.08563232421875
▁and 3.505859375
▁D 3.580078125
ial 4.67578125
ysis 0.45703125
" 2.431640625
▁provides 8.3828125
▁compreh 5.03515625
ensive 0.169921875
▁insight 4.6484375
▁into 3.0625
▁the 1.2998046875
▁leading 8.1171875
▁causes 6.3046875
▁of 0.9697265625
▁chron 2.724609375
ic 0.11865234375
▁infl 1.169921875
amm 0.055908203125
ation 0.0858154296875
▁in 1.5361328125
▁individuals 11.171875
▁suffering 6.32421875
▁from 0.68408203125
▁end 2.076171875
- 0.14501953125
stage 0.8310546875
▁ren 1.0810546875
al 0.3330078125
▁failure 10.03125
. 1.9873046875
▁As 4.52734375
▁a 1.2265625
▁high 6.90234375
- 0.8369140625
school 6.0
▁student 1.4970703125
, 0.73388671875
▁I 1.0771484375
▁found 4.2890625
▁this 2.884765625
▁article 1.9482421875
▁to 1.224609375
▁be 0.155517578125
▁quite 2.6875
▁en 3.498046875
light 0.00817108154296875
ening 0.004974365234375
▁and 1.6689453125
▁inform 2.5390625
ative 0.0200347900390625
. 0.81201171875
<0x0A> 2.244140625
Acc 5.7421875
ording 0.053314208984375
▁to 0.0135498046875
▁the 0.7763671875
▁article 1.126953125
, 0.52392578125
▁chron 2.958984375
ic 0.004177093505859375
▁infl 0.173583984375
amm 0.0170135498046875
ation 0.0017480850219726562
▁is 0.87646484375
▁a 1.1875
▁common 3.5390625
▁occurrence 3.03515625
▁in 0.79833984375
▁patients 3.228515625
▁with 1.150390625
▁end 0.431884765625
- 0.035736083984375
stage 0.0112152099609375
▁ren 0.04705810546875
al 0.00013124942779541016
▁disease 0.4521484375
▁( 1.4140625
ES 0.055206298828125
R 0.0017061233520507812
D 0.0014629364013671875
) 1.2841796875
▁and 0.92919921875
▁those 4.25
▁under 2.396484375
going 0.02545166015625
▁d 0.515625
ial 6.4373016357421875e-06
ysis 0.0007953643798828125
▁treatment 1.578125
. 0.2376708984375
▁The 1.96875
▁leading 5.25
▁causes 0.389892578125
▁of 0.096923828125
▁chron 0.09686279296875
ic 0.00021827220916748047
▁infl 0.007472991943359375
amm 0.0023670196533203125
ation 0.000370025634765625
▁in 0.84912109375
▁these 3.0390625
▁individuals 1.1630859375
▁include 1.583984375
▁repeated 7.08984375
▁d 4.05078125
ial 0.0032176971435546875
ysis 0.0178070068359375
- 5.484375
related 0.6513671875
▁in 1.337890625
fe 0.05780029296875
ctions 3.6954879760742188e-06
, 0.358154296875
▁v 5.28125
asc 0.1783447265625
ular 6.604194641113281e-05
▁access 1.5888671875
▁d 5.55859375
ys 0.055084228515625
function 0.08306884765625
, 0.1444091796875
▁and 0.9609375
▁the 2.88671875
▁presence 2.673828125
▁of 0.007762908935546875
▁middle 10.7734375
▁mole 5.125
cules 0.994140625
. 1.5888671875
▁Under 6.58203125
standing 0.228271484375
▁these 2.125
▁causes 1.970703125
▁is 1.8955078125
▁cru 2.228515625
cial 0.001987457275390625
▁to 1.1572265625
▁impro 3.06640625
ving 0.00096893310546875
▁the 0.8271484375
▁clin 5.16015625
ical 0.00444793701171875
▁out 0.84912109375
comes 0.0170135498046875
▁of 0.251953125
▁patients 1.203125
. 2.841796875
<0x0A> 0.484375
The 1.560546875
▁impact 6.6328125
▁of 0.1195068359375
▁chron 0.338623046875
ic 0.0003521442413330078
▁infl 0.01081085205078125
amm 0.00511932373046875
ation 0.0002493858337402344
▁on 0.64599609375
▁clin 6.00390625
ical 0.0068511962890625
▁out 0.1136474609375
comes 0.00011980533599853516
▁cannot 4.98828125
▁be 0.00658416748046875
▁under 1.06640625
st 0.3349609375
ated 0.00043773651123046875
. 0.166015625
▁It 2.63671875
▁is 1.0
▁associated 3.232421875
▁with 0.0010662078857421875
▁significant 3.751953125
▁mor 0.50146484375
bid 0.0007829666137695312
ity 0.09912109375
▁and 0.32470703125
▁mort 0.0450439453125
ality 6.031990051269531e-05
▁in 1.2080078125
▁E 1.6806640625
SR 0.003787994384765625
D 0.0003418922424316406
▁patients 0.118408203125
. 0.53271484375
▁For 3.359375
▁instance 1.8857421875
, 0.0007886886596679688
▁chron 1.2451171875
ic 0.0015201568603515625
▁infl 0.0938720703125
amm 0.005939483642578125
ation 0.0003161430358886719
▁can 1.7373046875
▁contribute 3.791015625
▁to 0.017913818359375
▁the 0.71533203125
▁development 0.3515625
▁of 0.04010009765625
▁card 2.76171875
i 0.1033935546875
ov 0.005367279052734375
asc 0.00015747547149658203
ular 2.5033950805664062e-06
▁disease 0.78369140625
, 0.72705078125
▁mal 7.7109375
nut 0.028717041015625
r 5.5789947509765625e-05
ition 0.00018894672393798828
, 0.01190948486328125
▁and 0.498046875
▁imp 4.87890625
a 0.024078369140625
ired 6.389617919921875e-05
▁imm 2.21875
une 0.322509765625
▁function 0.40966796875
. 0.250732421875
▁Moreover 3.0
, 0.00014698505401611328
▁it 1.6015625
▁can 0.49365234375
▁also 0.90478515625
▁lead 1.03125
▁to 0.0004982948303222656
▁poor 3.029296875
▁quality 1.6142578125
▁of 0.01035308837890625
▁life 0.00423431396484375
▁and 0.75927734375
▁increased 1.3583984375
▁hospital 1.3564453125
ization 0.703125
▁rates 1.1279296875
. 0.126220703125
<0x0A> 0.72021484375
One 4.453125
▁significant 5.85546875
▁aspect 2.703125
▁discussed 10.34375
▁in 0.055511474609375
▁the 0.313720703125
▁article 0.0268707275390625
▁is 0.248779296875
▁the 0.411376953125
▁role 1.5419921875
▁of 0.120361328125
▁middle 2.49609375
▁mole 0.01306915283203125
cules 0.0201873779296875
▁in 0.302001953125
▁the 1.2421875
▁development 0.75830078125
▁of 0.029632568359375
▁path 10.453125
ology 1.8466796875
. 0.8544921875
▁These 1.693359375
▁middle 4.21875
▁mole 0.003665924072265625
cules 0.00391387939453125
, 2.939453125
▁such 0.830078125
▁as 0.0005421638488769531
▁beta 6.921875
- 0.284912109375
2 2.521484375
▁micro 0.23583984375
glob 0.00884246826171875
ul 0.012847900390625
in 0.0140228271484375
, 0.7919921875
▁cy 5.60546875
tok 0.388427734375
ines 0.08551025390625
, 0.054718017578125
▁and 0.1541748046875
▁advanced 5.2890625
▁g 0.01271820068359375
ly 0.0014476776123046875
cation 0.0236358642578125
▁end 0.01454925537109375
- 1.9150390625
products 0.0241546630859375
, 0.3564453125
▁can 1.228515625
▁accum 3.84375
ulate 0.0004878044128417969
▁in 0.408447265625
▁E 2.923828125
SR 0.01503753662109375
D 0.0026493072509765625
▁patients 0.042938232421875
▁due 2.806640625
▁to 0.0004286766052246094
▁imp 3.7109375
a 0.0113525390625
ired 9.548664093017578e-05
▁ren 0.98876953125
al 0.0014324188232421875
▁function 0.238525390625
▁and 1.4794921875
▁in 4.03125
efficient 3.84375
▁d 1.208984375
ial 0.00728607177734375
ysis 0.0125885009765625
▁clear 6.51171875
ance 0.045684814453125
. 0.1348876953125
▁This 1.87890625
▁accum 0.96337890625
ulation 0.0097808837890625
▁cont 3.6953125
ributes 2.6226043701171875e-05
▁to 0.0175628662109375
▁chron 2.333984375
ic 0.00121307373046875
▁infl 0.01479339599609375
amm 0.0072174072265625
ation 6.0558319091796875e-05
▁and 0.43701171875
▁subsequent 2.80859375
▁t 2.7890625
issue 0.0031414031982421875
▁damage 0.255615234375
. 0.2061767578125
▁Under 5.0234375
standing 0.01052093505859375
▁the 0.1895751953125
▁role 0.28466796875
▁of 0.0302276611328125
▁middle 0.322021484375
▁mole 0.0016813278198242188
cules 0.0064544677734375
▁is 3.048828125
▁cru 1.080078125
cial 0.00023984909057617188
▁in 1.888671875
▁gu 5.08984375
iding 0.0004436969757080078
▁future 3.46484375
▁research 1.1611328125
▁and 0.50341796875
▁th 4.97265625
era 0.00011372566223144531
pe 5.364418029785156e-06
ut 2.086162567138672e-05
ic 0.060638427734375
▁inter 0.8515625
vent 0.1697998046875
ions 0.00010287761688232422
. 0.70556640625
<0x0A> 0.0506591796875
F 4.68359375
ort 4.91015625
un 0.040374755859375
ately 0.0017309188842773438
, 0.00547027587890625
▁there 0.85302734375
▁have 2.9453125
▁been 0.003231048583984375
▁recent 2.482421875
▁break 3.3046875
through 0.00035119056701660156
s 0.003589630126953125
▁and 4.87890625
▁on 7.28515625
going 0.01247406005859375
▁research 0.517578125
▁in 1.4755859375
▁d 5.53515625
ial 0.006305694580078125
ysis 0.0052032470703125
▁that 3.625
▁aim 3.4609375
▁to 0.03228759765625
▁stabil 8.921875
ize 0.00897979736328125
▁the 1.3544921875
▁condition 3.84765625
. 3.2109375
▁The 2.880859375
▁article 1.650390625
▁mentions 3.119140625
▁the 1.3388671875
▁util 6.609375
ization 0.006084442138671875
▁of 0.003757476806640625
▁hem 6.5625
odia 2.564453125
fil 0.0015583038330078125
tr 0.000335693359375
ation 0.0010890960693359375
▁and 1.8583984375
▁online 10.6953125
- 3.509765625
liver 9.109375
▁ad 9.9375
s 0.4189453125
or 0.072998046875
ption 0.08154296875
▁as 2.314453125
▁potential 1.923828125
▁treatment 1.7763671875
▁modal 2.693359375
ities 8.666515350341797e-05
. 0.70263671875
▁These 1.154296875
▁innov 2.876953125
ative 0.443115234375
▁approaches 2.3046875
▁have 1.6748046875
▁shown 1.716796875
▁promise 0.98681640625
▁in 0.153564453125
▁reducing 1.2958984375
▁middle 5.13671875
▁mole 0.057586669921875
c 0.2203369140625
ule 0.005100250244140625
▁concentr 2.8203125
ations 6.985664367675781e-05
▁and 0.55078125
▁impro 1.09765625
ving 4.935264587402344e-05
▁patient 2.259765625
▁out 0.33056640625
comes 0.001377105712890625
. 0.048675537109375
▁Additionally 2.810546875
, 0.0001957416534423828
▁the 1.19921875
▁use 2.625
▁of 0.0009484291076660156
▁bio 4.515625
compatible 2.51171875
▁d 2.583984375
ial 0.0049896240234375
ysis 0.4853515625
▁memb 0.469482421875
ran 0.034912109375
es 2.396106719970703e-05
▁has 1.6123046875
▁gained 6.1015625
▁attention 3.75
▁as 0.79833984375
▁a 0.289306640625
▁means 3.21875
▁to 0.564453125
▁reduce 1.234375
▁infl 3.751953125
amm 0.10009765625
ation 0.0011005401611328125
▁and 0.84375
▁enh 4.05078125
ance 0.00046443939208984375
▁d 1.53125
ial 0.0043487548828125
ysis 0.033935546875
▁efficiency 2.005859375
. 0.0301666259765625
<0x0A> 0.515625
In 2.169921875
▁conclusion 0.432373046875
, 0.000377655029296875
▁the 1.560546875
▁article 0.43115234375
▁sh 7.7421875
eds 0.01453399658203125
▁light 0.053863525390625
▁on 0.023681640625
▁the 0.2008056640625
▁leading 1.6748046875
▁causes 0.012786865234375
▁of 0.03973388671875
▁chron 0.007266998291015625
ic 6.532669067382812e-05
▁infl 0.0006351470947265625
amm 0.0003457069396972656
ation 0.00011801719665527344
▁in 0.07769775390625
▁individuals 2.0078125
▁with 1.5732421875
▁end 0.483154296875
- 0.005146026611328125
stage 0.01068878173828125
▁ren 0.00933074951171875
al 6.80685043334961e-05
▁disease 0.07415771484375
▁and 1.783203125
▁under 2.271484375
going 0.01568603515625
▁d 0.08514404296875
ial 3.4570693969726562e-06
ysis 0.0004718303680419922
. 3.037109375
▁It 1.103515625
▁emphas 3.203125
izes 0.003936767578125
▁the 0.053863525390625
▁det 8.8203125
r 0.006908416748046875
iment 6.54458999633789e-05
al 0.00026535987854003906
▁impact 1.2978515625
▁of 0.25830078125
▁chron 0.24609375
ic 0.00014448165893554688
▁infl 0.0016927719116210938
amm 0.00167083740234375
ation 5.7220458984375e-05
▁on 0.328125
▁clin 0.405517578125
ical 0.0003542900085449219
▁out 0.0162506103515625
comes 8.082389831542969e-05
▁and 0.716796875
▁the 2.40234375
▁role 3.431640625
▁of 0.2076416015625
▁middle 0.061248779296875
▁mole 0.0021800994873046875
cules 0.0108489990234375
▁in 0.04095458984375
▁the 0.7705078125
▁development 0.2210693359375
▁of 0.010650634765625
▁path 0.06414794921875
ology 0.0160675048828125
. 0.0205535888671875
▁Moreover 4.2265625
, 0.00016641616821289062
▁it 0.6923828125
▁presents 4.38671875
▁the 2.318359375
▁latest 2.25390625
▁break 2.15625
through 0.00021600723266601562
s 0.0185546875
▁and 0.350830078125
▁on 0.1461181640625
going 0.0020198822021484375
▁research 0.0043182373046875
▁in 0.41357421875
▁d 0.0704345703125
ial 3.0279159545898438e-05
ysis 0.0005512237548828125
▁that 0.61376953125
▁aim 0.06353759765625
▁to 0.0014934539794921875
▁stabil 0.0343017578125
ize 0.00042700767517089844
▁the 0.061737060546875
▁condition 0.030914306640625
. 0.216796875
▁As 2.916015625
▁a 0.300048828125
▁high 0.5244140625
- 0.1171875
school 0.004001617431640625
▁student 0.09320068359375
, 0.1881103515625
▁I 0.06427001953125
▁am 4.25
▁excited 2.8046875
▁to 0.2366943359375
▁see 2.2109375
▁adv 6.1015625
anc 0.258544921875
ements 1.9073486328125e-05
▁in 0.142822265625
▁the 0.9130859375
▁field 0.78515625
▁of 0.446533203125
▁d 0.324951171875
ial 0.0001569986343383789
ysis 0.00238037109375
▁that 3.384765625
▁can 2.224609375
▁potentially 1.9619140625
▁improve 0.50732421875
▁the 0.67236328125
▁lives 1.2607421875
▁of 0.010009765625
▁those 1.8330078125
▁affected 2.2578125
▁by 0.138916015625
▁end 0.6552734375
- 0.00847625732421875
stage 0.002986907958984375
▁ren 0.034393310546875
al 3.802776336669922e-05
▁failure 1.7861328125
. 0.112548828125
▁It 4.65625
▁is 0.41796875
▁my 1.39453125
▁hope 0.369140625
▁that 0.01389312744140625
▁further 3.626953125
▁research 0.1864013671875
▁and 1.0283203125
▁innov 0.95068359375
ation 0.6865234375
▁will 0.8896484375
▁lead 0.87451171875
▁to 0.012542724609375
▁better 2.412109375
▁treatment 1.90234375
▁options 0.5166015625
▁and 0.97412109375
▁en 5.0
hanced 0.013153076171875
▁quality 1.341796875
▁of 0.0213623046875
▁life 0.007587432861328125
▁for 0.349853515625
▁E 2.58984375
SR 0.001560211181640625
D 0.003078460693359375
▁patients 0.0283203125
. 0.1551513671875
